Published in Shanghai Arch Psychiatry on August 01, 2013
Electronic cigarettes: the new face of nicotine delivery and addiction. J Thorac Dis (2015) 0.77
No association between GSTM1 and GSTT1 genetic polymorphisms and susceptibility to opium sap dependence. Mol Biol Res Commun (2016) 0.75
The functions of animal microRNAs. Nature (2004) 64.85
Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science (2007) 32.97
A vision for the future of genomics research. Nature (2003) 14.06
Dopamine receptors: from structure to function. Physiol Rev (1998) 8.90
Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol (2001) 6.76
Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet (2004) 5.70
Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci (1992) 5.27
Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat Neurosci (2005) 4.83
Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science (1995) 4.59
Brain reward circuitry: insights from unsensed incentives. Neuron (2002) 3.98
Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology (2007) 3.73
Glutamatergic substrates of drug addiction and alcoholism. Biochem Pharmacol (2007) 3.06
Alcohol and aldehyde dehydrogenase genotypes and alcoholism in Chinese men. Am J Hum Genet (1991) 2.75
Interaction between the functional polymorphisms of the alcohol-metabolism genes in protection against alcoholism. Am J Hum Genet (1999) 2.73
Striatal microRNA controls cocaine intake through CREB signalling. Nature (2010) 2.56
Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol Psychiatry (2007) 2.55
Drug craving and addiction: integrating psychological and neuropsychopharmacological approaches. Prog Neuropsychopharmacol Biol Psychiatry (2003) 2.52
Cocaine sensitization and reward are under the influence of circadian genes and rhythm. Proc Natl Acad Sci U S A (2002) 2.40
Are there genetic influences on addiction: evidence from family, adoption and twin studies. Addiction (2008) 2.29
Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. Pharmacol Rev (2005) 2.23
Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res (1991) 2.21
There and back again: a tale of norepinephrine and drug addiction. Neuropsychopharmacology (2006) 2.17
Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metab Dispos (1996) 2.11
Pooled association genome scanning for alcohol dependence using 104,268 SNPs: validation and use to identify alcoholism vulnerability loci in unrelated individuals from the collaborative study on the genetics of alcoholism. Am J Med Genet B Neuropsychiatr Genet (2006) 2.09
Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. Proc Nutr Soc (2004) 2.09
Ethanol-responsive brain region expression networks: implications for behavioral responses to acute ethanol in DBA/2J versus C57BL/6J mice. J Neurosci (2005) 2.05
A genetic determinant of the striatal dopamine response to alcohol in men. Mol Psychiatry (2010) 2.02
Neurotrophic factors and structural plasticity in addiction. Neuropharmacology (2008) 1.99
Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence. Clin Pharmacol Ther (2005) 1.96
Addiction molecular genetics: 639,401 SNP whole genome association identifies many "cell adhesion" genes. Am J Med Genet B Neuropsychiatr Genet (2006) 1.95
Meta-analyses of ALDH2 and ADH1B with alcohol dependence in Asians. Psychol Bull (2006) 1.92
Tobacco smoking in China: prevalence, disease burden, challenges and future strategies. Respirology (2011) 1.83
Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations. Clin Pharmacol Ther (2006) 1.82
Polymorphism of ADH and ALDH genes among four ethnic groups in China and effects upon the risk for alcoholism. Alcohol Clin Exp Res (1997) 1.79
FE65 constitutes the functional link between the low-density lipoprotein receptor-related protein and the amyloid precursor protein. J Neurosci (2004) 1.79
Opiate addiction in China: current situation and treatments. Addiction (2006) 1.78
Brain-derived neurotrophic factor and cocaine addiction. Brain Res (2009) 1.76
Mu opioid receptor gene variants: lack of association with alcohol dependence. Mol Psychiatry (1998) 1.72
Genetics of dopamine receptors and drug addiction: a comprehensive review. Behav Pharmacol (2009) 1.72
Genetic approaches to addiction: genes and alcohol. Addiction (2008) 1.70
Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis (2004) 1.65
Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. J Psychopharmacol (2004) 1.58
Genetic and environmental influences on the development of alcoholism: resilience vs. risk. Ann N Y Acad Sci (2006) 1.57
Human monoamine oxidase A gene determines levels of enzyme activity. Am J Hum Genet (1991) 1.56
RACK1 and brain-derived neurotrophic factor: a homeostatic pathway that regulates alcohol addiction. J Neurosci (2004) 1.55
Drug addiction: pathways to the disease and pathophysiological perspectives. Eur Neuropsychopharmacol (2006) 1.48
Alcohol dehydrogenase and alcohol dependence: variation in genotype-associated risk between populations. Am J Hum Genet (2002) 1.47
Drug abuse in China: past, present and future. Cell Mol Neurobiol (2007) 1.46
Pathways of sexual desire. J Sex Med (2009) 1.44
Sleep, sleep-dependent procedural learning and vigilance in chronic cocaine users: Evidence for occult insomnia. Drug Alcohol Depend (2005) 1.44
A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning. Neuroreport (2005) 1.40
Association between alcohol use and smoking in adolescent and young adult twins: a bivariate genetic analysis. Alcohol Clin Exp Res (1997) 1.38
Addiction and brain reward and antireward pathways. Adv Psychosom Med (2011) 1.38
Regulation of beta-amyloid secretion by FE65, an amyloid protein precursor-binding protein. J Biol Chem (1999) 1.38
Genetics of human alcohol-metabolizing enzymes. Prog Nucleic Acid Res Mol Biol (1991) 1.38
Differential allelic expression of dopamine D1 receptor gene (DRD1) is modulated by microRNA miR-504. Biol Psychiatry (2009) 1.37
Heroin addiction in African Americans: a hypothesis-driven association study. Genes Brain Behav (2009) 1.32
A genomewide search finds major susceptibility loci for nicotine dependence on chromosome 10 in African Americans. Am J Hum Genet (2006) 1.31
Genetic polymorphisms in monoamine neurotransmitter systems show only weak association with acute post-surgical pain in humans. Mol Pain (2006) 1.30
Neurobiology of alcohol dependence: focus on motivational mechanisms. Alcohol Res Health (2008) 1.29
Genetics of human alcohol and aldehyde dehydrogenases. Adv Hum Genet (1986) 1.28
Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET. Science (1987) 1.26
Human liver alcohol dehydrogenase: purification and kinetic characterization of the beta 2 beta 2, beta 2 beta 1, alpha beta 2, and beta 2 gamma 1 "Oriental" isoenzymes. Biochemistry (1984) 1.25
The genetic components of alcohol and nicotine co-addiction: from genes to behavior. Curr Drug Abuse Rev (2008) 1.25
Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice. Behav Pharmacol (2008) 1.23
The role of neurotrophic factors in psychostimulant-induced behavioral and neuronal plasticity. Rev Neurosci (2001) 1.23
Association between mu opioid receptor gene polymorphisms and Chinese heroin addicts. Neuroreport (2001) 1.22
Molecular genetic underpinnings of human substance abuse vulnerability: likely contributions to understanding addiction as a mnemonic process. Neuropharmacology (2004) 1.20
Molecular neuroanatomy of human monoamine oxidases A and B revealed by quantitative enzyme radioautography and in situ hybridization histochemistry. Neuroscience (1996) 1.18
Drug addiction in China. Ann N Y Acad Sci (2008) 1.18
Noradrenaline in the bed nucleus of the stria terminalis is critical for stress-induced reactivation of morphine-conditioned place preference in rats. Eur J Pharmacol (2001) 1.17
Seroprevalence of hepatitis C markers among intravenous drug users in western European countries: a systematic review. J Viral Hepat (2002) 1.17
Gene x disease interaction on orbitofrontal gray matter in cocaine addiction. Arch Gen Psychiatry (2011) 1.14
Increased drinking in a metropolitan city in China: a study of alcohol consumption patterns and changes. Addiction (2008) 1.13
Recent trends in drug abuse in China. Acta Pharmacol Sin (2006) 1.13
Contributions of serotonin in addiction vulnerability. Neuropharmacology (2011) 1.12
Genome-wide association studies of alcohol dependence and substance use disorders. Curr Psychiatry Rep (2011) 1.11
Association study of brain-derived neurotrophic factor gene polymorphism and alcoholism. Alcohol Clin Exp Res (2004) 1.11
Potentiated opioid analgesia in norepinephrine transporter knock-out mice. J Neurosci (2000) 1.11
Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin. Hum Mutat (2002) 1.11
Ethanol-associated behaviors of mice lacking norepinephrine. J Neurosci (2000) 1.11
Immunocytochemical localization of monoamine oxidases A and B in human peripheral tissues and brain. J Histochem Cytochem (1987) 1.09
Yohimbine stress potentiates conditioned cue-induced reinstatement of heroin-seeking in rats. Behav Brain Res (2009) 1.09
Kinetic and electrophoretic properties of native and recombined isoenzymes of human liver alcohol dehydrogenase. Biochemistry (1983) 1.08
The MAOA promoter polymorphism, disruptive behavior disorders, and early onset substance use disorder: gene-environment interaction. Psychiatr Genet (2007) 1.08
Possible interaction of alcohol dehydrogenase and aldehyde dehydrogenase genes with the dopamine D2 receptor gene in anxiety-depressive alcohol dependence. Alcohol Clin Exp Res (2004) 1.07
No association between alcoholism and multiple polymorphisms at the dopamine D2 receptor gene (DRD2) in three distinct Taiwanese populations. Biol Psychiatry (1996) 1.07
Long-term morphine treatment decreases the association of mu-opioid receptor (MOR1) mRNA with polysomes through miRNA23b. Mol Pharmacol (2009) 1.04
Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction. J Neurochem (2009) 1.04
Chronic intermittent ethanol exposure and its removal induce a different miRNA expression pattern in primary cortical neuronal cultures. Alcohol Clin Exp Res (2011) 1.04
The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin. J Med Chem (2000) 1.03
Reawakening the dragon: changing patterns of opiate use in Asia, with particular emphasis on China's Yunnan province. Subst Use Misuse (2001) 1.03
Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients. Pharmacogenomics (2011) 1.03
Genetic variation of hepatitis C virus in a cohort of injection heroin users in Wuhan, China. Virus Res (2008) 1.02
No association between (AAT)n repeats in the cannabinoid receptor gene (CNR1) and heroin abuse in a Chinese population. Mol Psychiatry (2000) 1.02
Cocaine dependence and acute cocaine induce decreases of monocyte proinflammatory cytokine expression across the diurnal period: autonomic mechanisms. J Pharmacol Exp Ther (2006) 1.02
Effect of mu-opioid receptor gene polymorphisms on heroin-induced subjective responses in a Chinese population. Biol Psychiatry (2006) 1.01
Regulation of norepinephrine transporter abundance by catecholamines and desipramine in vivo. Brain Res (2002) 1.00
Developmental expression of monoamine oxidases A and B in the central and peripheral nervous systems of the mouse. J Comp Neurol (2002) 0.97
The role of mPer1 in morphine dependence in mice. Neuroscience (2005) 0.97
An unconditioned stimulus retrieval extinction procedure to prevent the return of fear memory. Biol Psychiatry (2014) 1.15
Effect of conditioned stimulus exposure during slow wave sleep on fear memory extinction in humans. Sleep (2015) 0.86
A comparative clinical study of the effects of the traditional Chinese medicine Jinniu capsules and lofexidine on acute heroin withdrawal symptoms. Am J Drug Alcohol Abuse (2008) 0.80
Monocyte mediated brain targeting delivery of macromolecular drug for the therapy of depression. Nanomedicine (2014) 0.76
Comparing three extinction methods to reduce fear expression and generalization. Behav Brain Res (2021) 0.75